About this episode

This episode discusses the shift in glaucoma care towards integrating ocular surface resilience into management strategies.

CME credits: 1.00 Valid until: 20-04-2027 Claim your CME credit at https://reachmd.com/programs/cme/beyond-iop-integrating-ocular-surface-resilience-into-glaucoma-management/49097/ Glaucoma care is shifting from a narrow focus on pressure targets to a broader, patient-centered approach that balances durable intraocular pressure (IOP) control with preservation of the ocular surface, comfort, and real-world adherence. But, daily practice often still defaults to drop-heavy regimens that can erode the very ocular surface on which long-term success depends. The chronic use of preserved topical medications can compromise the cornea and conjunctiva, perpetuating ocular surface disease (OSD) and ocular surface inflammation (OSI). These conditions not only degrade comfort and quality of life but also undermine adherence, accelerate treatment failure, and reduce the success rates of both medical and surgical interventions. Recent expert consensus underscores that every glaucoma patient should be screened for OSD/OSI, yet implementation remains inconsistent in daily practice. Contemporary perspectives and data support a shift toward ocular surface-sparing strategies, including…

Topics covered

• glaucoma management
• ocular surface resilience
• patient-centered care
• intraocular pressure control
• ocular surface disease
• treatment adherence

Keywords

• glaucoma
• ocular surface
• CME
• intraocular pressure
• treatment strategies
• ocular surface disease
• patient adherence

Mentioned in this episode

Organizations: ReachMD

Products: preservative-free options, tear-restorative, anti-inflammatory, neuromodulatory therapeutic options

More episodes of ReachMD CME

• Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities · April 24, 2026 · 14 min
• Retina Rumble: Debating Modern Treatment Options · April 15, 2026 · 33 min
• Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source · April 7, 2026 · 14 min
• Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider! · March 31, 2026 · 16 min
• Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors · March 31, 2026 · 14 min
• The Future of HNSCC: Aligning Teams, Transforming Care · March 31, 2026 · 16 min

Explore listener stats, chart rankings, contacts and more on the ReachMD CME podcast page.